Stay updated on EDP-305 Safety and Efficacy in NASH Clinical Trial
Sign up to get notified when there's something new on the EDP-305 Safety and Efficacy in NASH Clinical Trial page.

Latest updates to the EDP-305 Safety and Efficacy in NASH Clinical Trial page
- Check6 days agoChange DetectedFatty Liver Disease was replaced with Steatotic Liver Disease on the page to reflect updated nomenclature for liver fat–related conditions. This terminology change updates how the condition is described and searched within the study context.SummaryDifference0.0%

- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedA new site revision label, v3.6.3, appears on the page. This indicates a platform update and does not modify the study details or user-facing actions.SummaryDifference0.0%

- Check27 days agoChange DetectedThe revision label was updated from v3.6.0 to v3.6.2, indicating a newer build of the site. This appears to be a deployment-level update rather than content changes on the page.SummaryDifference0.0%

- Check41 days agoChange DetectedRecruitment status updated to 'No longer looking for participants', and new help sections were added (How to Read a Study Record, Common Questions, How to Join a Study). A formatting change to the Intervention/Treatment heading and a revision version update from v3.5.5 to v3.6.0 were applied.SummaryDifference0.3%

- Check48 days agoChange DetectedThe page shows Revision: v3.5.5, indicating a new version of the study record. This appears to be a minor metadata update rather than a change to the study details or results.SummaryDifference0.0%

- Check70 days agoChange DetectedA new page revision label v3.5.4 has been added, replacing the previous v3.5.3. This indicates an updated version of the page, likely reflecting minor edits or refinements but not changes to core study details.SummaryDifference0.0%

Stay in the know with updates to EDP-305 Safety and Efficacy in NASH Clinical Trial
Enter your email address, and we'll notify you when there's something new on the EDP-305 Safety and Efficacy in NASH Clinical Trial page.